| Antimicrobial Agent | Susceptibility Profile | Clinical Interpretation |
|---|---|---|
| Amikacin | Sensitive | <=2 |
| Amoxicillin/Clavulanic acid | Sensitive | <=2 |
| Ampicillin | Resistant | >=32 |
| Cefepime | Sensitive | <=1 |
| Cefotaxime | Sensitive | <0.125 |
| Ceftazidime | Sensitive | 0.25 |
| Ceftriaxone | Sensitive | <=1 |
| Cefuroxime | Sensitive | 2 |
| Ciprofloxacin | Sensitive | <=0.25 |
| Colistin | Intermediate | <0.125 |
| Ertapenem | Sensitive | <=0.5 |
| Gentamicin | Sensitive | <=1 |
| Imipenem | Sensitive | <=0.25 |
| Levofloxacin | Resistant | <0.125 |
| Meropenem | Sensitive | <=0.25 |
| Nalidixic acid | Sensitive | <=2 |
| Nitrofurantoin | Sensitive | 32 |
| Piperacillin/Tazobactam | Sensitive | <=4 |
| Tobramycin | Sensitive | 0.5 |
| Trimethoprim/Sulfamethoxazole | Sensitive | <=20 |
| Resistant Gene Track | Detection Methodology | NCBI Genome Accession |
|---|---|---|
| oqxA | PCR | |
| oqxB | PCR |